Sustained virological response following an 11-day course of direct acting antiviral therapy for hepatitis C infection

J Gastrointestin Liver Dis. 2020 Jun 4;29(2):270. doi: 10.15403/jgld-2153.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • 2-Naphthylamine
  • Anilides / therapeutic use
  • Antiviral Agents / therapeutic use*
  • Carbamates / therapeutic use
  • Cyclopropanes / therapeutic use
  • Cytochrome P-450 CYP3A Inhibitors / therapeutic use*
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
  • Lactams, Macrocyclic / therapeutic use
  • Middle Aged
  • Proline / analogs & derivatives
  • Proline / therapeutic use
  • Ritonavir / therapeutic use
  • Simvastatin / adverse effects
  • Sulfonamides / therapeutic use
  • Sustained Virologic Response*
  • Uracil / analogs & derivatives
  • Uracil / therapeutic use
  • Valine

Substances

  • Anilides
  • Antiviral Agents
  • Carbamates
  • Cyclopropanes
  • Cytochrome P-450 CYP3A Inhibitors
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lactams, Macrocyclic
  • Sulfonamides
  • ombitasvir
  • Uracil
  • Proline
  • Simvastatin
  • 2-Naphthylamine
  • dasabuvir
  • Valine
  • Ritonavir
  • paritaprevir